{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T15:25:43Z","timestamp":1770996343218,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005969","name":"Universit\u00e0 di Bologna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005969","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.clnu.2020.07.028","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T11:33:24Z","timestamp":1596022404000},"page":"1176-1185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Assessment of adverse reactions to \u03b1-lipoic acid containing dietary supplements through spontaneous reporting systems"],"prefix":"10.1016","volume":"40","author":[{"given":"Milo","family":"Gatti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Ippoliti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Poluzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ippazio Cosimo","family":"Antonazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola Angela","family":"Moro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5108-5807","authenticated-orcid":false,"given":"Ugo","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Menniti-Ippolito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Mazzanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0367-9595","authenticated-orcid":false,"given":"Fabrizio","family":"De Ponti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0487-7996","authenticated-orcid":false,"given":"Emanuel","family":"Raschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clnu.2020.07.028_bib2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/1060028017744316","article-title":"Dietary supplement adverse event report data from the FDA center for food safety and applied nutrition adverse event reporting system (CAERS), 2004\u20132013","volume":"52","author":"Timbo","year":"2018","journal-title":"Ann Pharmacother"},{"issue":"8","key":"10.1016\/j.clnu.2020.07.028_bib3","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s40264-018-0661-3","article-title":"Adverse events to food supplements containing red yeast rice: comparative analysis of FAERS and CAERS reporting systems","volume":"41","author":"Raschi","year":"2018","journal-title":"Drug Saf"},{"issue":"4","key":"10.1016\/j.clnu.2020.07.028_bib4","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/bcp.13171","article-title":"Adverse reactions to dietary supplements containing red yeast rice: assessment of cases from the Italian surveillance system","volume":"83","author":"Mazzanti","year":"2017","journal-title":"Br J Clin Pharmacol"},{"issue":"16","key":"10.1016\/j.clnu.2020.07.028_bib5","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1056\/NEJMsa1504267","article-title":"Emergency department visits for adverse events related to dietary supplements","volume":"373","author":"Geller","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.clnu.2020.07.028_bib6","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1517\/13543776.2014.937425","article-title":"Therapeutic applications of lipoic acid: a patent review (2011\u20132014)","volume":"24","author":"Koufaki","year":"2014","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.clnu.2020.07.028_bib7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3390\/biom9080356","article-title":"Insight on the use of \u03b1-lipoic acid for therapeutic purposes","volume":"9","author":"Salehi","year":"2019","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.clnu.2020.07.028_bib8","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1080\/17512433.2016.1189326","article-title":"Herbal medicines: challenges in the modern world. Part 2. European Union and Russia","volume":"9","author":"Sammons","year":"2016","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.clnu.2020.07.028_bib9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jep.2012.01.051","article-title":"Pharmacovigilance of herbal medicine","volume":"140","author":"Shaw","year":"2012","journal-title":"J\u00a0Ethnopharmacol"},{"issue":"6","key":"10.1016\/j.clnu.2020.07.028_bib10","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/pds.1566","article-title":"Surveillance of suspected adverse reactions to natural health products in Italy","volume":"17","author":"Menniti-Ippolito","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"10.1016\/j.clnu.2020.07.028_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00228-011-1128-y","article-title":"Surveillance of suspected adverse reactions to herbal products used as laxatives","volume":"68","author":"Vitalone","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.clnu.2020.07.028_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00228-010-0981-4","article-title":"Suspected adverse reactions associated with herbal products used for weight loss: a case series reported to the Italian National Institute of Health","volume":"67","author":"Vitalone","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.clnu.2020.07.028_bib13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/cen.12334","article-title":"Insulin autoimmune syndrome (Hirata disease) in European caucasians taking \u03b1-lipoic acid","volume":"81","author":"Gullo","year":"2014","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.clnu.2020.07.028_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nut.2018.04.010","article-title":"Potential cause-effect relationship between insulin autoimmune syndrome and alpha lipoic acid: two case reports","volume":"57","author":"Moffa","year":"2019","journal-title":"Nutrition"},{"key":"10.1016\/j.clnu.2020.07.028_bib15","article-title":"Insulin autoimmune syndrome in an Argentine woman taking \u03b1-lipoic acid: a case report and review of the literature","volume":"6","author":"Izzo","year":"2018","journal-title":"SAGE Open Med Case Rep"},{"key":"10.1016\/j.clnu.2020.07.028_bib16","article-title":"Spontaneously remitting insulin autoimmune syndrome in a patient taking alpha-lipoic acid","volume":"2018","author":"Cappellani","year":"2018","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"1","key":"10.1016\/j.clnu.2020.07.028_bib17","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.diabres.2008.10.015","article-title":"Drug-induced insulin autoimmune syndrome","volume":"83","author":"Uchigata","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.clnu.2020.07.028_bib18","doi-asserted-by":"crossref","first-page":"1126.e5","DOI":"10.1016\/j.ajem.2018.03.030","article-title":"First description of the alpha lipoic acid intoxication in an adult patient worldwide following oral administration","volume":"36","author":"Gulen","year":"2018","journal-title":"Am J Emerg Med"},{"issue":"8","key":"10.1016\/j.clnu.2020.07.028_bib19","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/15563650.2018.1551545","article-title":"Multiple organ failure and shock following acute alpha lipoic acid (ALA) intoxication","volume":"57","author":"Moretti","year":"2019","journal-title":"Clin Toxicol"},{"issue":"1","key":"10.1016\/j.clnu.2020.07.028_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/(SICI)1099-1557(199801\/02)7:1<51::AID-PDS319>3.0.CO;2-B","article-title":"Postmarketing surveillance of adverse drug reactions: a correlational study approach using multiple data sources","volume":"7","author":"Rathmann","year":"1998","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.clnu.2020.07.028_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s40264-015-0353-1","article-title":"The contribution of national spontaneous reporting systems to detect signals of torsadogenicity: issues emerging from the ARITMO project","volume":"39","author":"Raschi","year":"2016","journal-title":"Drug Saf"},{"key":"10.1016\/j.clnu.2020.07.028_bib22","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","article-title":"Adverse drug reactions: definitions, diagnosis, and management","volume":"356","author":"Edwards","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.clnu.2020.07.028_bib25","series-title":"Designated medical event (DME) list","author":"European Medicines Agency","year":"2016"},{"issue":"6","key":"10.1016\/j.clnu.2020.07.028_bib26","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.2903\/j.efsa.2011.2202","article-title":"Scientific Opinion on the substantiation of health claims related to alpha-lipoic acid and \u201cprotection of the nerve system\u201d (ID 3157) and increase in insulin sensitivity (ID 3158) pursuant to article 13(1) of regulation (EC) no 1924\/2006","volume":"9","author":"EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)","year":"2011","journal-title":"EFSA Journal"},{"issue":"4","key":"10.1016\/j.clnu.2020.07.028_bib27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/jamainternmed.2015.8581","article-title":"Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011","volume":"176","author":"Qato","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"8","key":"10.1016\/j.clnu.2020.07.028_bib28","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/jamapediatrics.2018.1008","article-title":"Prevalence of dietary supplement use in US children and adolescents, 2003\u20132014","volume":"172","author":"Qato","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"14","key":"10.1016\/j.clnu.2020.07.028_bib29","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/jama.2016.14403","article-title":"Trends in dietary supplement use among US adults from 1999\u20132012","volume":"316","author":"Kantor","year":"2016","journal-title":"J\u00a0Am Med Assoc"},{"issue":"4","key":"10.1016\/j.clnu.2020.07.028_bib30","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1530\/EJE-12-0555","article-title":"A\u00a0systematic review and meta-analysis of \u03b1-lipoic acid in the treatment of diabetic peripheral neuropathy","volume":"167","author":"Han","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.clnu.2020.07.028_bib31","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/obr.12528","article-title":"Alpha-lipoic acid (ALA) as a supplementation for weight loss: results from a meta-analysis of randomized controlled trials","volume":"18","author":"Kucukgoncu","year":"2017","journal-title":"Obes Rev"},{"key":"10.1016\/j.clnu.2020.07.028_bib32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2019.01.065","article-title":"The effect of alpha-lipoic acid on inflammatory mediators: a systematic review and meta-analysis on randomized clinical trials","volume":"849","author":"Haghighatdoost","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.clnu.2020.07.028_bib33","doi-asserted-by":"crossref","first-page":"101486","DOI":"10.1016\/j.msard.2019.101486","article-title":"RELIEF trial team. The effect of emerging nutraceutical interventions for clinical and biological outcomes in multiple sclerosis: a systematic review","volume":"37","author":"Marx","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.clnu.2020.07.028_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.metabol.2018.07.002","article-title":"The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials","volume":"87","author":"Akbari","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.clnu.2020.07.028_bib35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.ejcn.1602932","article-title":"Prevalence and characteristics of vitamin or dietary supplement users in Lausanne, Switzerland: the CoLaus study","volume":"63","author":"Marques-Vidal","year":"2009","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.clnu.2020.07.028_bib36","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s12603-013-0418-8","article-title":"The use of dietary supplements among older persons in southern Germany \u2013 results from the KORA-age study","volume":"18","author":"Schwab","year":"2014","journal-title":"J\u00a0Nutr Health Aging"},{"issue":"11","key":"10.1016\/j.clnu.2020.07.028_bib37","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.clinthera.2011.09.024","article-title":"Changes in herb and dietary supplement use in the U.S. adult population: a comparison of the 2002 and 2007 National health interview surveys","volume":"33","author":"Wu","year":"2011","journal-title":"Clin Ther"},{"key":"10.1016\/j.clnu.2020.07.028_bib38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/YIC.0000000000000132","article-title":"Adjunctive \u03b1-lipoic acid reduces weight gain compared with placebo at 12 weeks in schizophrenic patients treated with atypical antipsychotics: a double-blind randomized placebo-controlled study","volume":"31","author":"Kim","year":"2016","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.clnu.2020.07.028_bib39","first-page":"189857","article-title":"Treatment with alpha-lipoic acid over 16 weeks in type 2 diabetic patients with symptomatic polyneuropathy who responded to initial 4-week high-dose loading","volume":"2015","author":"Garcia-Alcala","year":"2015","journal-title":"J\u00a0Diabetes Res"},{"issue":"2","key":"10.1016\/j.clnu.2020.07.028_bib40","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.clnu.2017.06.002","article-title":"Alpha-lipoic acid supplement in obesity treatment: a systematic review and meta-analysis of clinical trials","volume":"37","author":"Namazi","year":"2018","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1016\/j.clnu.2020.07.028_bib41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000356145","article-title":"Does lipoic acid consumption affect the cytokine profile in multiple sclerosis patients: a double-blind, placebo-controlled, randomized clinical trial","volume":"21","author":"Khalili","year":"2014","journal-title":"Neuroimmunomodulation"},{"issue":"1","key":"10.1016\/j.clnu.2020.07.028_bib42","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00281-015-0540-2","article-title":"Adverse cutaneous drug eruptions: current understanding","volume":"38","author":"Hoetzenecker","year":"2016","journal-title":"Semin Immunopathol"},{"issue":"6","key":"10.1016\/j.clnu.2020.07.028_bib43","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1179\/acb.2009.090","article-title":"Drug hypersensitivity","volume":"64","author":"Yawalkar","year":"2009","journal-title":"Acta Clin Belg"},{"issue":"3","key":"10.1016\/j.clnu.2020.07.028_bib44","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/cod.12472","article-title":"Further evidence of thioctic acid (\u03b1-lipoic acid) being a strong cosmetic sensitizer","volume":"74","author":"Leysen","year":"2016","journal-title":"Contact Dermatitis"},{"issue":"1","key":"10.1016\/j.clnu.2020.07.028_bib45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.0105-1873.2006.0847c.x","article-title":"Contact dermatitis to alpha-lipoic acid in an anti-wrinkle cream","volume":"55","author":"Bergqvist-Karlsson","year":"2006","journal-title":"Contact Dermatitis"},{"issue":"6","key":"10.1016\/j.clnu.2020.07.028_bib46","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/cod.12716","article-title":"Contact allergy to thioctic acid present in Hypromellose\u00ae eye drops","volume":"76","author":"Craig","year":"2017","journal-title":"Contact Dermatitis"},{"issue":"1","key":"10.1016\/j.clnu.2020.07.028_bib47","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/cod.12393","article-title":"Delayed hypersensitivity to \u03b1-lipoic acid: look at dietary supplements","volume":"73","author":"Rizzi","year":"2015","journal-title":"Contact Dermatitis"},{"issue":"3","key":"10.1016\/j.clnu.2020.07.028_bib48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0168-8227(90)90063-Y","article-title":"Insulin autoimmune syndrome is the third leading cause of spontaneous hypoglycemic attacks in Japan","volume":"10","author":"Takayama-Hasumi","year":"1990","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.clnu.2020.07.028_bib49","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1515\/cclm-2017-0392","article-title":"Insulin autoimmune syndrome (Hirata's disease) in an Italian patient: a case report and review of the literature","volume":"56","author":"Censi","year":"2018","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"10.1016\/j.clnu.2020.07.028_bib50","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0198-8859(99)00144-5","article-title":"Worldwide differences in the incidence of insulin autoimmune syndrome (Hirata disease) with respect to the evolution of HLA-DR4 alleles","volume":"61","author":"Uchigata","year":"2000","journal-title":"Hum Immunol"},{"issue":"4","key":"10.1016\/j.clnu.2020.07.028_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/ph9040065","article-title":"Herbal products in Italy: the thin line between phytotherapy, nutrition and parapharmaceuticals; A normative overview of the fastest growing market in Europe","volume":"9","author":"Biagi","year":"2016","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.clnu.2020.07.028_bib52","first-page":"39","article-title":"Pilot study for the surveillance of adverse reactions to herbal preparations and dietary supplements","volume":"41","author":"Menniti-Ippolito","year":"2005","journal-title":"Ann Ist Super Sanita"},{"issue":"8","key":"10.1016\/j.clnu.2020.07.028_bib53","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep4.1088","article-title":"Drug-induced cholestasis","volume":"1","author":"Sundaram","year":"2017","journal-title":"Hepatol Commun"},{"issue":"11","key":"10.1016\/j.clnu.2020.07.028_bib54","first-page":"1169","article-title":"Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf causality assessment method","volume":"14","author":"Teschke","year":"2018","journal-title":"Expert Opin Drug MetabToxicol"},{"key":"10.1016\/j.clnu.2020.07.028_bib55","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3389\/fphar.2019.00730","article-title":"Idiosyncratic DILI: analysis of 46,266 cases assessed for causality by RUCAM and published from 2014 to early 2019","volume":"10","author":"Teschke","year":"2019","journal-title":"Front Pharmacol"},{"issue":"13","key":"10.1016\/j.clnu.2020.07.028_bib56","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.4254\/wjh.v7.i13.1761","article-title":"Drug- and herb-induced liver injury: progress, current challenges and emerging signals of post-marketing risk","volume":"7","author":"Raschi","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.clnu.2020.07.028_bib57","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3389\/fphar.2019.01326","article-title":"Analysis of hepatobiliary disorder reports associated with the use of herbal medicines in the global suspected ADR database vigibase","volume":"10","author":"van Hunsel","year":"2019","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.clnu.2020.07.028_bib58","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3390\/nu6020815","article-title":"Prevalence of dietary supplement use in healthy pre-school Chinese children in Australia and China","volume":"6","author":"Chen","year":"2014","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.clnu.2020.07.028_bib59","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12875-017-0699-9","article-title":"Factors associated with the use of dietary supplements and over-the-counter medications in Japanese elderly patients","volume":"19","author":"Masumoto","year":"2018","journal-title":"BMC Fam Pract"},{"issue":"1","key":"10.1016\/j.clnu.2020.07.028_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40264-012-0005-7","article-title":"Pharmacovigilance of herbal medicines: the potential contributions of ethnobotanical and ethnopharmacological studies","volume":"36","author":"Rodrigues","year":"2013","journal-title":"Drug Saf"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561420303939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561420303939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:59:55Z","timestamp":1759366795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561420303939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0261561420303939"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2020.07.028","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of adverse reactions to \u03b1-lipoic acid containing dietary supplements through spontaneous reporting systems","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2020.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}